id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-E-0079-0004,FDA,FDA-2004-E-0079,Determination of Regulatory Review Period for Purposes of Patent Extension; REYATAZ,Notice,General Notice,2004-09-28T04:00:00Z,2004,9,2004-09-28T04:00:00Z,,2025-11-07T18:03:16Z,04-21625,0,0,090000648046ed8f
FDA-2004-E-0079-0003,FDA,FDA-2004-E-0079,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2004-09-02T04:00:00Z,2004,9,,,2025-11-07T17:26:53Z,,0,0,090000648046ed8e
FDA-2004-E-0079-0002,FDA,FDA-2004-E-0079,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2004-07-15T04:00:00Z,2004,7,,,2025-11-07T17:24:32Z,,0,0,090000648046ed8d
FDA-2004-E-0079-0001,FDA,FDA-2004-E-0079,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2004-04-09T04:00:00Z,2004,4,,,2025-11-07T17:21:54Z,,0,0,090000648046ed87